Table of Content

1 Executive Summery
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Incidence of Anaphylaxis
4.2.2 Growing Prevalence of Targeted Therapies
4.3 Restraints
4.3.1 Increased Product Recall
4.3.2 Stringent Regulatory Policies
4.4 Opportunities
4.4.1 Entering Developing Economies
4.5 Challenges
4.5.1 Lack of Proper Training for Using Autoinjectors
4.6 Macroeconomic Indicators
4.7 Technology Trends & Assessment
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Monitoring
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Autoinjectors Market, By Product Type
6.1 Overview
6.2 Disposable Autoinjectors
6.3 Reusable Autoinjectors
7 Global Autoinjectors Market, BY Design
7.1 Overview
7.2 Customized Autoinjectors
7.3 Standardized Autoinjectors
8 Global Autoinjectors Market, By Therapeutic Application
8.1 Overview
8.2 Anaphylaxis
8.3 Rheumatoid Arthritis
8.4 Multiple Sclerosis
8.5 Diabetes
8.6 Others
9 Global Autoinjectors Market, By Distribution Channel
9.1 Overview
9.2 Retail Pharmacies
9.3 Hospital Pharmacies
9.4 Others
10 Global Autoinjectors Market, By Region
10.1 Overview
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 UK
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
11.2 Company Ranking
12 Company Profiles
12.1 Amgen Inc.
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 Becton, Dickinson and Company
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 Abbvie Inc.
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 Mylan N.V.
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 Eli Lilly and Company
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 Ypsomed
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Owen Mumford Ltd
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Consort Medical
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 SHL Group
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.1 Johnson & Johnson Services Inc.
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
12.11 Teva Pharmaceutical Industries Ltd
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products/Services Offered
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategies
12.12 Antares Pharma
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products/Services Offered
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategies
13 Appendix
13.1 References
13.2 Related Reports



List of Figures



FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL AUTOINJECTORS MARKET: MARKET STRUCTURE
FIGURE 3 RESEARCH PROCESS
FIGURE 4 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 5 VALUE CHAIN: GLOBAL AUTOINJECTORS MARKET
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL AUTOINJECTORS MARKET
FIGURE 7 GLOBAL AUTOINJECTORS MARKET SHARE, BY PRODUCT TYPE, 2018 (%)
FIGURE 8 GLOBAL AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2018 & 2024 (USD MILLION)
FIGURE 9 GLOBAL AUTOINJECTORS MARKET SHARE, BY DESIGN, 2018 (%)
FIGURE 10 GLOBAL AUTOINJECTORS MARKET, BY DESIGN, 2018 & 2024 (USD MILLION)
FIGURE 11 GLOBAL AUTOINJECTORS MARKET SHARE, BY THERAPEUTIC APPLICATION, 2018 (%)
FIGURE 12 GLOBAL AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2018 & 2024 (USD MILLION)
FIGURE 13 GLOBAL AUTOINJECTORS MARKET SHARE, BY DISTRIBUTION CHANNEL, 2018 (%)
FIGURE 14 GLOBAL AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2018 & 2024 (USD MILLION)
FIGURE 15 GLOBAL AUTOINJECTORS MARKET SHARE, BY REGION, 2018 (%)
FIGURE 16 GLOBAL AUTOINJECTORS MARKET, BY REGION, 2018 & 2024 (USD MILLION)
FIGURE 17 AMERICAS: AUTOINJECTORS MARKET SHARE, BY REGION, 2018 (%)
FIGURE 18 NORTH AMERICA: AUTOINJECTORS MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 19 EUROPE: AUTOINJECTORS MARKET SHARE, BY REGION, 2018 (%)
FIGURE 20 WESTERN EUROPE: AUTOINJECTORS MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 21 ASIA-PACIFIC: AUTOINJECTORS MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 22 MIDDLE EAST & AFRICA: AUTOINJECTORS MARKET SHARE, BY REGION, 2018 (%)

 

List of Tables



TABLE 1 PRIMARY INTERVIEWS
TABLE 2 GLOBAL AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 3 GLOBAL AUTOINJECTORS MARKET, FOR DISPOSABLE AUTOINJECTORS, BY REGION, 2016–2024 (USD MILLION)
TABLE 4 GLOBAL AUTOINJECTORS MARKET, FOR REUSABLE AUTOINJECTORS, BY REGION, 2016–2024 (USD MILLION)
TABLE 5 GLOBAL AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 6 GLOBAL AUTOINJECTORS MARKET, FOR CUSTOMIZED AUTOINJECTORS, BY REGION, 2016–2024 (USD MILLION)
TABLE 7 GLOBAL AUTOINJECTORS MARKET, FOR STANDARDIZED AUTOINJECTORS, BY REGION, 2016–2024 (USD MILLION)
TABLE 8 GLOBAL AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 9 GLOBAL AUTOINJECTORS MARKET, FOR ANAPHYLAXIS, BY REGION, 2016–2024 (USD MILLION)
TABLE 10 GLOBAL AUTOINJECTORS MARKET, FOR RHEUMATOID ARTHRITIS, BY REGION, 2016–2024 (USD MILLION)
TABLE 11 GLOBAL AUTOINJECTORS MARKET, FOR MULTIPLE SCLEROSIS, BY REGION, 2016–2024 (USD MILLION)
TABLE 12 GLOBAL AUTOINJECTORS MARKET, FOR DIABETES, BY REGION, 2016–2024 (USD MILLION)
TABLE 13 GLOBAL AUTOINJECTORS MARKET, FOR OTHERS, BY REGION, 2016–2024 (USD MILLION)
TABLE 14 GLOBAL AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 15 GLOBAL AUTOINJECTORS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2016–2024 (USD MILLION)
TABLE 16 GLOBAL AUTOINJECTORS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2016–2024 (USD MILLION)
TABLE 17 GLOBAL AUTOINJECTORS MARKET, FOR OTHERS, BY REGION, 2016–2024 (USD MILLION)
TABLE 18 GLOBAL AUTOINJECTORS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 19 AMERICAS: AUTOINJECTORS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 20 AMERICAS: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 21 AMERICAS: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 22 AMERICAS: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 23 AMERICAS: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: AUTOINJECTORS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 29 US: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 30 US: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 31 US: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 32 US: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 33 CANADA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 34 CANADA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 35 CANADA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 36 CANADA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 37 LATIN AMERICA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 38 LATIN AMERICA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 39 LATIN AMERICA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 40 LATIN AMERICA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 41 EUROPE: AUTOINJECTORS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 42 EUROPE: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 43 EUROPE: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 44 EUROPE: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 45 EUROPE: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 46 WESTERN EUROPE: AUTOINJECTORS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 47 WESTERN EUROPE: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 48 WESTERN EUROPE: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 49 WESTERN EUROPE: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 50 WESTERN EUROPE: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 51 GERMANY: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 52 GERMANY: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 53 GERMANY: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 54 GERMANY: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 55 FRANCE: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 56 FRANCE: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 57 FRANCE: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 58 FRANCE: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 59 UK: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 60 UK: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 61 UK: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 62 UK: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 63 ITALY: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 64 ITALY: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 65 ITALY: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 66 ITALY: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 67 SPAIN: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 68 SPAIN: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 69 SPAIN: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 70 SPAIN: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 71 REST OF WESTERN EUROPE: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 72 REST OF WESTERN EUROPE: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 73 REST OF WESTERN EUROPE: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 74 REST OF WESTERN EUROPE: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 75 EASTERN EUROPE: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 76 EASTERN EUROPE: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 77 EASTERN EUROPE: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 78 EASTERN EUROPE: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 79 ASIA-PACIFIC: AUTOINJECTORS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 80 ASIA-PACIFIC: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 81 ASIA-PACIFIC: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 82 ASIA-PACIFIC: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 83 ASIA-PACIFIC: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 84 JAPAN: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 85 JAPAN: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 86 JAPAN: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 87 JAPAN: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 88 CHINA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 89 CHINA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 90 CHINA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 91 CHINA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 92 INDIA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 93 INDIA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 94 INDIA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 95 INDIA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 96 AUSTRALIA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 97 AUSTRALIA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 98 AUSTRALIA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 99 AUSTRALIA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 100 SOUTH KOREA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 101 SOUTH KOREA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 102 SOUTH KOREA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 103 SOUTH KOREA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 104 REST OF ASIA-PACIFIC: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 105 REST OF ASIA-PACIFIC: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 106 REST OF ASIA-PACIFIC: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 107 REST OF ASIA-PACIFIC: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 108 MIDDLE EAST & AFRICA: AUTOINJECTORS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 112 MIDDLE EAST & AFRICA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 113 MIDDLE EAST: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 114 MIDDLE EAST: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 115 MIDDLE EAST: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 116 MIDDLE EAST: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 117 AFRICA: AUTOINJECTORS MARKET, BY PRODUCT TYPE, 2016–2024 (USD MILLION)
TABLE 118 AFRICA: AUTOINJECTORS MARKET, BY DESIGN, 2016–2024 (USD MILLION)
TABLE 119 AFRICA: AUTOINJECTORS MARKET, BY THERAPEUTIC APPLICATION, 2016–2024 (USD MILLION)
TABLE 120 AFRICA: AUTOINJECTORS MARKET, BY DISTRIBUTION CHANNEL, 2016–2024 (USD MILLION)
TABLE 121 TOP MANUFACTURERS OF GLOBAL AUTOINJECTORS MARKET